Davion Healthcare (DAVI) announced Monday that it has completed the acquisition of the intellectual property relating to two medical technologies WoundSkan and the Spektra Lateral Flow Test for $25M from the four shareholders of Humaskan.
The company highlighted that $25M comprised $2.5M